Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 10873 - 10880 of 11616 results
Second Circuit Applies the Filed Rate Doctrine to Electricity Rates Set by Market-Based Auctions
October 29, 2012| Blog| Viewpoint
Barnes & Noble PIN Pad Devices Hit By Hackers
October 25, 2012| Blog| Viewpoint
Congratulations to Geri Haight, Winner of INTA's 2012 Volunteer Service Award
October 22, 2012| Blog| Viewpoint
House Committee Moving Forward with Subpoena Regarding Medicare Advantage Demonstration Project
October 22, 2012| Blog| Viewpoint
Video Interview: Discussing Eagle v. Edcomm, the LinkedIn Employer Takeover Case, with LXBN TV
October 18, 2012| Blog| Viewpoint
Does the NLRA really Protect A Worker's Right to Be Rude? The NLRB Thinks So!
October 17, 2012| Blog| Viewpoint
Court Decision in Sony PlayStation Data Breach Case Places Burden on Plaintiffs to Allege Actual Damages
October 17, 2012| Blog| Viewpoint
Confounding Issues about Compounding Pharmacy Regulation*
October 17, 2012| Blog| Viewpoint
News & Press Releases
Mintz Announces New Members
December 20, 2024
Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.
Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.
Dealmaking Dormant No More
December 17, 2024
International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.